New Multitarget Rivastigmine-Indole Hybrids as Potential Drug Candidates for Alzheimer's Disease.

Authors:
Bon L; Banaś A; Dias I; Melo-Marques I; Cardoso SM and 2 more

Journal:
Pharmaceutics

Publication Year: 2024

DOI:
10.3390/pharmaceutics16020281

PMCID:
PMC10892719

PMID:
38399339

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pharmaceutics

Abbreviation: Pharmaceutics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
3D-Printed Alginate/Pectin-Based Patches Loaded with Olive Leaf Extracts for Wound Healing Applicat…
Patitucci F; Motta MF; Dattilo M and 8 more (2024) - Transparency Score: 3/6
3D Printing of Biodegradable Polymeric Microneedles for Transdermal Drug Delivery Applications.
Aldawood FK; Parupelli SK; Andar A and 1 more (2024) - Transparency Score: 3/6
4-(Phenylselanyl)-2H-chromen-2-one-Loaded Nanocapsule Suspension-A Promising Breakthrough in Pain M…
da Fonseca CAR; Prado VC; Paltian JJ and 10 more (2024) - Transparency Score: 4/6
A Bilayer Microarray Patch (MAP) for HIV Pre-Exposure Prophylaxis: The Role of MAP Designs and Form…
Vora LK; Tekko IA; Zanutto FV and 7 more (2024) - Transparency Score: 3/6
Acylation of Oleanolic Acid Oximes Effectively Improves Cytotoxic Activity in In Vitro Studies.
Bednarczyk-Cwynar B; Ruszkowski P. (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare no conflicts of interest."

Evidence found in paper:

"This work was supported by the Portuguese Fundação para a Ciência e Tecnologia (FCT), through project grants: UIDB/00100/2020 (https://doi.org/10.54499/UIDB/00100/2020, UIDP/00100/2020, [M1] https://doi.org/10.54499/UIDP/00100/2020 (CQE), UIDB/04539/2020, PINFRA/22184/2016 UIDB/04539/2020 (DOI: 10.54499/UIDB/04539/2020), UIDP/04539/2020 (DOI: 10.54499/UIDP/04539/2020), LA/P/0058/2020 (DOI: 10.54499/LA/P/0058/2020) and PTDC/MED-NEU/3644/2020 (DOI: 10.54499/PTDC/MED-NEU/3644/2020); I.M.-M. is supported by a Cure PD contract under the project GAinPD_SC01; A.B. acknowledges the Erasmus+ program for an international fellowship."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025